Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Malnutrition 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Body Weight Changes 1

Interventions

Carboplatin 25Etoposide 23Cisplatin 16pembrolizumab 9Topotecan 9atezolizumab 7Pemetrexed 7Nivolumab 7Radiosurgery 6Irinotecan 5durvalumab 4Paclitaxel 4Gemcitabine 4Albumin-Bound Paclitaxel 4rovalpituzumab tesirine 3etoposide phosphate 3Radiotherapy 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Cyclophosphamide 3vistusertib 2roniciclib 2pelcitoclax 2pazopanib 2epacadostat 2amrubicin 2Vorinostat 2Radiation 2Fluorodeoxyglucose F18 2Doxorubicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Small Cell Lung Carcinoma × Nutrition Therapy × Clear all
NCT00769652 2023-10-03

Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer

Rutgers, The State University of New Jersey

Phase NA Terminated
8 enrolled 6 charts
GastrointestinalGenitourinaryThoracic

Body Weight Changes, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Malnutrition, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡